alexa A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia | Open Access Journals
ISSN: 1747-0862
Journal of Molecular and Genetic Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

A novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia

Vajira HW Dissanayake1,2*, Jayan D Jayasinghe1, Viranga Tilakaratna2, Rohan W Jayasekara1

1Human Genetics Unit, Faculty of Medicine, University of Colombo, Sri Lanka

2Asiri Centre for Genomic and Regenerative Medicine, Asiri Surgical Hospital, Colombo, Sri Lanka

*Corresponding Author:
Vajira Dissanayake
Tel: +94 777351835
Fax: +94 112689979
Email: vajirahwd@hotmail.com

Received date: 26 March 2011, Accepted date: 05 April 2011, Published online 18 May 2011

Citation: J Mol Genet Med, 2010, Vol 5, 262-263

© Copyright The Authors: This is an open access article, published under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/). This license permits noncommercial use, distribution and reproduction of the article, provided the original work is appropriately acknowledged with correct citation details.

Visit for more related articles at Journal of Molecular and Genetic Medicine

Glycogen storage disease type Ib (GSD Ib) [MIM 232220] is caused by mutations in the gene encoding microsomal glucose-6-phosphate translocase (G6PT) (Veiga-Da- Cunha et al, 1998). This solute carrier family 37, member 4 gene (SLC37A4) is located on chromosome 11q23.3 and encodes a 429 amino acid polypeptide (Veiga-Da-Cunha et al, 1998). This protein transports glucose-6-phosphate into the endoplasmic reticulum, where the enzyme glucose-6-phosphatase converts glucose-6-phosphate into glucose and inorganic phosphate. Mutations in SLC37A4 result in accumulation of glucose-6-phosphate in cells. The SLC37A4 gene has 9 exons and so far 83 mutations have been reported (Human Gene Mutation Database, 2011). Here, we report the identification of a novel mutation in the SLC37A4 gene in a Sri Lankan child and the associated clinical phenotype.

This child was a three month old baby boy – the first child born to a consanguineous Sinhalese couple. The child had had pyrexia and umbilical sepsis few days after birth and recurrent, generalized pustular skin eruptions on and off since then. His abdomen was protruding. He had had persistent neutropenia, confirmed by haematological tests from the age of 3 weeks. Physical examination showed a grossly enlarged liver. He weighed 5.8Kg (Birth weight: 3.6Kg). The weight was within the 50th percentile.

Investigation findings were as follows: Fasting blood glucose: 66mg/dl (reference interval: 65-110mg/dl); plasma lactate: 89.8mg/dl (reference interval: 4.5- 19.8mg/dl); serum uric acid: 8.54mg/dl (reference interval: 2.4-7.0mg/dl); serum triglycerides: 1236mg/dl (reference interval: 10 -200mg/dl); serum cholesterol: 242mg/dl (reference interval: 140-239 mg/dl); Alanine transaminase (ALT): 225.3U/l (reference interval: <40U/l); Aspartate transaminase (AST): 566.5U/l (reference interval: <40U/l), Alkaline phosphetase: 795.5U/l (reference interval: 98- 279U/l) and Gamma glutaryl transferase: 960.1U/l (reference interval: 7-50U/l).

The neutrophil count in the peripheral blood was frequently fluctuating between 0.2×103/μl and 0.9×103/μl (reference interval: 1.5-9.0×103/μl) throughout this period. Bone marrow biopsy and peripheral blood picture were otherwise normal except for the low neutrophil counts. Based on the above clinical and laboratory findings, a clinical diagnosis of GSD type I was determined. First mutation analysis of the glucose-6-phosphatase (G6PC) gene was undertaken to confirm/exclude GSD Ia. No mutations were found in the G6PC gene. This was followed by screening for mutations in SLC37A4 gene to confirm/exclude GSD Ib. Genetic testing in both instances was done after obtaining written informed consent from the parents. Genomic DNA was extracted from the child’s peripheral venous blood. All the exons and intron-exon boundaries of the G6PC and SLC37A4 genes were analyzed. Direct sequencing of PCR products was performed on both forward and reverse strands using the same primers for PCR. Cycle sequencing was performed with a BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems, Foster City, CA, USA). The sequence was read following capillary electrophoresis on an ABI 3130 Genetic Analyzer (Applied Biosystems). The sequence was compared with the reference sequence (NG_013331.1 RefSeqGene) in the National Center for Biotechnology Information database (http://www.ncbi.nlm.nih.gov). Detailed methods can be provided on request.

Sequence analysis showed that codon 50 of the SLC37A4 gene was converted from GGG to GAG by the substitution of a Guanine nucleotide by an Adenine nucleotide (Figure 1). This results in the substitution of Glyceine (G) by Glutemic acid (E) in the amino acid sequence of the G6PT protein [p.G50E].

molecular-genetic-medicine-Electropherogram

Figure 1: Electropherogram of the sense strand nucleotide sequence of the SLC37A4 gene. The arrow indicates Guanine → Adenine substitution at codon 50 in exon 1, resulting in the p.G50E missense mutation.

GSD type I or von Gierke disease includes a clinically, biochemically, and genetically heterogeneous group of autosomal recessive disorders. The basic defects reside in the impairment of the terminal steps of glycogenolysis and gluconeogenesis, at different levels. Mutations of the G6PC gene are responsible for the most frequent form of GSD type I, the subtype Ia. In GSD Ia, the white blood cell count is generally within reference ranges because leukocyte function is unaffected by the defect. In contrast, chronic neutropenia due to impaired function of neutrophils, is found in GSD Ib (Visser et al, 2000). The clinical manifestations of GSD type I include growth retardation, hepatomegaly, hypoglycemia, lactic acidemia, hyperuricemia, and hyperlipidemia. In addition, patients with GSD Ib commonly have infectious complications which are caused by neutropenia and dysfunction of neutrophils. The diagnosis of GSD type I is based on its clinical presentation; i.e., abnormal plasma concentrations of glucose, lactate, uric acid, triglycerides, lipids; liver biopsy to measure enzyme activity; and molecular genetic testing (Visser et al, 2000).

This child had all the clinical and biochemical parameters suggestive of GSD Ia, except persistent neutropenia. Individuals with GSD Ia who are homozygous for the p.G188R mutation in the G6PC gene have been reported with GSD Ib like phenotype with neutropaenia (Weston et al, 2000). This child was tested for mutations in the G6PC gene to exclude this possibility. In untreated patients with GSD Ib, neutropenia usually manifests after about 1 year of age (Weston et al, 2000). In this child however, neutrophils were significantly reduced, with recurrent skin sepsis almost from birth.

In summary, we identified a missence mutation in the SLC37A4 gene [p.G50E] in a Sri Lankan child with clinical and laboratory findings suggestive of the diagnosis of GSD Ib. This is a new mutation which has not been described before in other children with GSD Ib and it appears that it is associated with very early onset neutorpaenia.

Acknowledgements

This research was funded by the University of Colombo and Asiri Surgical Hospial, Sri Lanka.

Competing Intersting

None declared.

List of Abbrevations

GSD - Glycogen Storage Disease

G6PC - Glucose 6-phosphatase

G6PT - Glucose-6-Phosphate Translocase

SLC37A4 - Solute Carrier Family 37, Member 4 Gene

References

  1. Human Gene Mutation Database. 2011. http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC37A4 (visited on 5 April 2011).
  2. Veiga-da-Cunha M, Gerin I, Chen YT et al. 1998. A gene on chromosome 11q23 coding for a putative glucose-6- phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet, 63, 976-983.
  3. Visser G, Rake JP, Fernandes J et al. 2000. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr, 137, 187-191.
  4. Weston BW, Lin JU, Muenzer J et al. 2000. Glucose-6- Phosphatase Mutation G188R Confers an Atypical Glycogen Storage Disease Type 1b Phenotype. Pediatr Res, 48, 329-334.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 3rd Antibodies and Bio Therapeutics Congress & B2B
    November 08-09, 2017 Las Vegas, Nevada, USA
  • 19th World Congress on Biotechnology
    November 13-14, 2017 Osaka, Japan
  • 4th World Conference on Synthetic Biology and Genetic Engineering
    November 9-10, 2017 Singapore City, Singapore

Article Usage

  • Total views: 11678
  • [From(publication date):
    December-2011 - Oct 17, 2017]
  • Breakdown by view type
  • HTML page views : 7933
  • PDF downloads :3745
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords